DOI: 10.12890/2023_004157

Familial renal glucosuria presenting as paroxysmal glucosuria and hypercalciuria due to a novel SLC5A2 heterozygous variant

Authors

  • Robin Van Lerberghe Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium
  • Elien Mahieu Department of Nephrology, AZ Glorieux, Ronse, Belgium
  • Johan Vanuytsel Department of Nephrology, AZ Glorieux, Ronse, Belgium
  • Karen Vanhaute Department of Nephrology, AZ Glorieux, Ronse, Belgium
  • Celine Vanfraechem Department of Nephrology, AZ Glorieux, Ronse, Belgium
  • Laurens Claeys Department of Nephrology, AZ Glorieux, Ronse, Belgium

laurens.claeys@azglorieux.be

Keywords

Familial renal glucosuria, SLC5A2 variant

Abstract

Familial renal glucosuria (FRG) is a rare genetic disease characterised by isolated glucosuria in the absence of proximal tubular dysfunction. It usually occurs due to a mutation in the SLC5A2 gene encoding the sodium-glucose cotransporter-2 (SGLT2), responsible for most of the renal glucose reabsorption. We report on a case of a patient presenting with paroxysmal glucosuria and hypercalciuria due to a novel SLC5A2 heterozygous variant.

View the entire article

Downloads

References

  1. Wright EM, Loo DDF, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev 2011;91:733–794.
  2. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405–424.
  3. Li S, Yang Y, Huang L, Kong M, Yang Z. A novel compound heterozygous mutation in SLC5A2 contributes to familial renal glucosuria in a Chinese family, and a review of the relevant literature. Mol Med Rep 2019;49:4364–4376.
  4. Santer R, Calado J. Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target. Clin J Am Soc Nephrol 2010;5:133–141.
  5. Ren Q, Gong S, Han X, Ji L. Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitor. J Diabetes 2022;14:216–220.

Published

2023-11-20

How to Cite

1.
Van Lerberghe R, Mahieu E, Vanuytsel J, Vanhaute K, Vanfraechem C, Claeys L. Familial renal glucosuria presenting as paroxysmal glucosuria and hypercalciuria due to a novel SLC5A2 heterozygous variant. EJCRIM [Internet]. 2023 Nov. 20 [cited 2026 Nov. 3];10(12). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4157

Most read articles by the same author(s)